News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

PHARMAC releases Australia vs NZ comparison

Media release

PHARMAC releases data on Australia vs NZ comparison

PHARMAC has released its data on comparisons between medicines subsidised in New Zealand and Australia.

In response to comments on the comparison, PHARMAC has issued a spreadsheet on its website www.pharmac.govt.nz

In summary, the spreadsheet shows that New Zealand has more funded chemicals or formulations of the same chemical with distinctly different uses (e.g. ketoconazole tablets vs ketoconazole shampoo). New Zealand has 717 and Australia 655.

The comparison is summarised in the following table:

NZ unique Australia unique Shared Overlap
Chemicals 267 217 416 46%
Chemical/formulation (use) 280 218 437 47%
Brand 1042 1897 617 17%

PHARMAC chief executive Wayne McNee says the reason that numbers are different to those issued by the Researched Medicines Industry Association appears to be because of the different products included or excluded from each list. For example, the RMI analysis includes all pharmaceutical cancer treatments used in hospitals; PHARMAC’s excludes those not listed in the community Pharmaceutical Schedule.

“We are comfortable with the numbers produced in our analysis, and which we have provided to the Minister of Health,” comments Wayne McNee. “To be more transparent about what we are saying, we are happy to release this information to the public.”

Wayne McNee says more brands of pharmaceuticals are funded in Australia, because more than one brand of the same off-patent medicine is often funded. In New Zealand, PHARMAC tenders for one supplier and uses price competition to obtain the best price for off-patent (generic) medicines.

ENDS

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Legendary Bassist David Friesen Plays Wellington’s Newest Jazz Venue

Friesen is touring New Zealand to promote his latest album Another Time, Another Place, recorded live at Auckland's Creative Jazz Club in 2015. More>>

Howard Davis Review: The Father - Descending Into The Depths of Dementia

Florian Zeller's dazzling drama The Father explores the effects of a deeply unsettling illness that affects 62,000 Kiwis, a number expected to grow to 102,000 by 2030. More>>


Howard Davis Review: Blade Runner Redivivus

When Ridley Scott's innovative, neo-noir, sci-fi flick Blade Runner was originally released in 1982, at a cost of over $45 million, it was a commercial bomb. More>>

14-21 October: New Zealand Improv Festival In Wellington

Imagined curses, Shibuya’s traffic, the apocalypse, and motherhood have little in common, but all these and more serve as inspiration for the eclectic improvised offerings coming to BATS Theatre this October for the annual New Zealand Improv Festival. More>>

ALSO:

Bird Of The Year Off To A Flying Start

The competition asks New Zealanders to vote for their favourite bird in the hopes of raising awareness of the threats they face. More>>

Scoop Review Of Books:
Jenny Abrahamson's John & Charles Enys: Castle Hill Runholders, 1864-1891

This volume will be of interest to a range of readers interested in the South Island high country, New Zealand’s natural environment, and the history of science. More>>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION